Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 270 entries
View as:

Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01859143 Org: User:
Start: 05/31/13 End: 12/31/13 Due: 12/31/14

MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00072930 Org: User:
Start: 12/31/03 End: 06/30/07 Due: 06/30/08

A Study of the Inflammatory Pathways Associated With Chronic Obstructive Pulmonary Disease Exacerbations

Phase: N/A Priority: Normal
NCT ID: NCT01337661 Org: User:
Start: 04/30/11 End: 02/29/12 Due: 02/28/13

MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States

Phase: N/A Priority: Normal
NCT ID: NCT00121108 Org: User:
Start: 11/15/04 End: 12/27/10 Due: 12/27/11

Study to Evaluate the Safety and Efficacy of CAT-354

Phase: N/A Priority: Normal
NCT ID: NCT00873860 Org: User:
Start: 06/30/09 End: 08/31/10 Due: 08/31/11

Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03444584 Org: User:
Start: 05/08/18 End: 12/06/18 Due: 12/06/19

A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT03244800 Org: User:
Start: 09/04/17 End: 01/23/18 Due: 01/23/19

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01248949 Org: User:
Start: 10/31/10 End: 10/31/15 Due: 10/31/16

A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT01438489 Org: User:
Start: 01/31/12 End: 04/30/15 Due: 04/30/16

Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00192257 Org: User:
Start: 10/31/02 End: 05/31/03 Due: 05/31/04

Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT00192270 Org: User:
Start: 10/31/00 End: 01/31/01 Due: 01/31/02

A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00816361 Org: User:
Start: 03/09/09 End: 09/11/12 Due: 09/11/13

Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants

Phase: N/A Priority: Normal
NCT ID: NCT00384462 Org: User:
Start: 10/31/06 End: 01/31/08 Due: 01/31/09

Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01446159 Org: User:
Start: 06/13/11 End: 06/28/19 Due: 06/28/20

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

Phase: N/A Priority: Normal
NCT ID: NCT02027961 Org: User:
Start: 12/20/13 End: 04/24/18 Due: 04/24/19

Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)

Phase: N/A Priority: Normal
NCT ID: NCT01030536 Org: User:
Start: 02/15/10 End: 03/04/13 Due: 03/04/14

A Study to Evaluate the Safety of H1N1 Monovalent Vaccine (MEDI3414) in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00945893 Org: User:
Start: 08/31/09 End: 03/31/10 Due: 03/31/11

A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness

Phase: N/A Priority: Normal
NCT ID: NCT00421304 Org: User:
Start: 01/10/07 End: 09/17/09 Due: 09/17/10

D2560C00015 FluMist Annual Safety Study 2018

Phase: N/A Priority: Normal
NCT ID: NCT03564444 Org: User:
Start: 06/06/18 End: 12/27/18 Due: 12/27/19

A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children

Phase: N/A Priority: Normal
NCT ID: NCT00344305 Org: User:
Start: 05/01/06 End: 12/01/06 Due: 12/01/07

Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease

Phase: N/A Priority: Normal
NCT ID: NCT00123942 Org: User:
Start: 04/30/04 End: - Due: -

Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program

Phase: N/A Priority: Normal
NCT ID: NCT00192218 Org: User:
Start: 10/31/04 End: 04/30/05 Due: 04/30/06

A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Phase: N/A Priority: Normal
NCT ID: NCT01453205 Org: User:
Start: 02/27/12 End: 07/11/16 Due: 07/11/17

A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children

Phase: N/A Priority: Normal
NCT ID: NCT01091246 Org: User:
Start: 03/31/10 End: 12/31/10 Due: 12/31/11

Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Malignant Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00111696 Org: User:
Start: 05/31/05 End: 11/30/07 Due: 11/30/08